In the Deloitte Intelligent Drug Discovery article, Figure 1 refers to the History of Drug Discovery and the Year 2019; AI-enabled technology for de novo design of small-molecules (GENTRL) by Insilico Medicine delivered a lead compound against fibrosis in 46 days rather than years

The use of the approach GENTRL what class of drug was successfully targeted? 

Article here: https://doi.org/10.1038/s41587-019-0224-x

From what you know of kinase inhibitors, what do you think would be a key part of the screening steps to make a successful drug?

A clue: https://www.nature.com/articles/s41587-019-0224-x/figures/8